Preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; preparations for the treatment of auto-immune diseases.

Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations ...

Pharmaceutical preparations, namely, immunosuppressants; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19, pharmaceutical preparations for the treatment of arteritis, pharmaceutical preparations for suppressing cytokines, pharmaceutical preparations for the treatment of lung diseases, pharmaceutical preparations for immunity adjustment, pharmaceutical preparations for the treatment of auto-immune diseases